SCHEMBL10050378

SCHEMBL10050378

N#CN=C1c2cc(-c3cccc(F)c3)ccc2-c2ccc(-c3cccc(F)c3)cc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 3/20 0.43
ESR2 Q92731 1/20 0.43
PARP10 Q53GL7 1/20 0.38
PARP11 Q9NR21 1/20 0.38
PDK2 Q15119 1/20 0.38
PGR P06401 1/20 0.38
KDM4E B2RXH2 1/20 0.38
HPGD P15428 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
PDE4B Q07343 2/20 0.37
GABRG2 P18507 1/20 0.37
GABRB3 P28472 1/20 0.37
GABRA5 P31644 1/20 0.37
GABRA3 P34903 1/20 0.37
CYP17A1 P05093 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP11B1 P15538 1/20 0.36
CYP11B2 P19099 1/20 0.36
ADORA2A P29274 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10050375 0.87 PGR (0.35) PGRCYP11B1CYP11B2MAP4K4
SCHEMBL10050379 0.85 CYP11B2 (0.37) PDK2PGRKDM4ENPSR1PDE4B
SCHEMBL10050381 0.81 TDP2 (0.41) ESR2KDM4EHPGDGABRG2GABRB3
SCHEMBL10050374 0.80 CTSS (0.43) PARP10PARP11PGRKDM4E
SCHEMBL10050377 0.80 GABRG2 (0.34) ESR2GABRG2GABRB3GABRA5GABRA3
SCHEMBL10050382 0.79 ESR1 (0.33) ESR2CYP11B1CYP11B2PTPN1
SCHEMBL12118009 0.78 TAAR1 (0.31) TAAR1ESR2KDM4EHPGDNPSR1
SCHEMBL10050380 0.77 PTPRC (0.54) PDK2PDE4BCYP11B1CYP11B2ADORA1
SCHEMBL10075600 0.75 MMP3 (0.42) PDK2PGRGABRG2GABRB3GABRA5
SCHEMBL10075609 0.74 ESR2 (0.47) TAAR1ESR2PARP10PARP11PDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119828-B2 Material for an organic electroluminescence device and an organic electroluminescence device IDEMITSU KOSAN CO., LTD. (JP) 2012-02-21 US disclosed
US-8119828-B2 Material for an organic electroluminescence device and an organic electroluminescence device IDEMITSU KOSAN CO., LTD. (JP) 2012-02-21 US disclosed
US-20100044686-A1 MATERIAL FOR AN ORGANIC ELECTROLUMINESCENCE DEVICE AND AN ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2010-02-25 US disclosed
US-20100044686-A1 MATERIAL FOR AN ORGANIC ELECTROLUMINESCENCE DEVICE AND AN ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2010-02-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100044686-A1 MATERIAL FOR AN ORGANIC ELECTROLUMINESCENCE DEVICE AND AN ORGANIC ELECTROLUMINESCENCE DEVICE AFF4, KCNH3, HCN4 TAAR1 402/4885ESR2 717/4885PARP10 3070/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.